These Egln1 tie2 Cre mice developed an irreversible obliterative vascular remodeling and pathophysiology similar to described in patients with severe PAH (idiopathic PAH), an effect that could be reverted using a HIF-2α translation inhibitor C76 (compound 76). The gene discussed is EGLN1; the disease is pulmonary arterial hypertension.